A Study of VBP-245 in Pediatric Patients With Molluscum Contagiosum
Status:
Completed
Trial end date:
2018-04-27
Target enrollment:
Participant gender:
Summary
A Multicenter, Randomized, Double-Blind, Vehicle-Controlled Phase II Study to Evaluate the
Efficacy, Tolerability, and Safety of Topical VBP-245 in Pediatric Subjects for the Treatment
of Molluscum Contagiosum (VBP-245-MCV).